Volume | 1,290 |
|
|||||
News | (1) | ||||||
Day High | 2.0712 | Low High |
|||||
Day Low | 1.90 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
ProMIS Neurosciences Inc | PMN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.0712 | 1.90 | 2.0712 | 1.9999 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
9 | 1,290 | US$ 2.01 | US$ 2,596 | - | 0.95 - 8.95 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
11:54:44 | 50 | US$ 2.00 | USD |
ProMIS Neurosciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
857.93k | 8.58M | - | 0 | -13.21M | -1.54 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ProMIS Neurosciences News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PMN Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.06 | 2.18 | 1.90 | 2.00 | 4,608 | -0.0603 | -2.93% |
1 Month | 2.05 | 2.61 | 1.63 | 2.18 | 16,014 | -0.0503 | -2.45% |
3 Months | 2.01 | 2.61 | 1.46 | 2.06 | 17,588 | -0.0103 | -0.51% |
6 Months | 1.76 | 3.10 | 0.95 | 1.99 | 31,828 | 0.2397 | 13.62% |
1 Year | 6.91 | 8.95 | 0.95 | 4.33 | 109,050 | -4.91 | -71.06% |
3 Years | 6.94 | 9.80 | 0.95 | 4.37 | 61,573 | -4.94 | -71.19% |
5 Years | 6.94 | 9.80 | 0.95 | 4.37 | 61,573 | -4.94 | -71.19% |
ProMIS Neurosciences Description
ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It primarily operates in Canada. |